Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:COVCVE:HEMNASDAQ:MDNANASDAQ:PDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOV(COV)$0.00$65.97▼$108.57N/AN/A3.88 million shsN/AHEMHemostemixC$0.14+3.8%C$0.11C$0.04▼C$0.43C$19.67M0.2423,049 shs72,300 shsMDNAMedicenna Therapeutics$0.29$0.15▼$0.84$10.93M1.3160,047 shs1.27 million shsPDPInvesco Dorsey Wright Momentum ETF$107.72+0.6%$103.78$86.41▼$117.67$1.28B1.0222,013 shs55,474 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOV(COV)0.00%0.00%0.00%0.00%0.00%HEMHemostemix0.00%0.00%+17.39%+45.16%+92.86%MDNAMedicenna Therapeutics0.00%0.00%0.00%0.00%0.00%PDPInvesco Dorsey Wright Momentum ETF0.00%+2.98%+2.44%+7.74%+10.08%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCOV(COV)N/AN/AN/AN/AN/AN/AN/AN/AHEMHemostemixN/AN/AN/AN/AN/AN/AN/AN/AMDNAMedicenna Therapeutics1.2681 of 5 stars3.50.00.00.00.01.70.0PDPInvesco Dorsey Wright Momentum ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOV(COV) 0.00N/AN/AN/AHEMHemostemix 0.00N/AN/AN/AMDNAMedicenna Therapeutics 3.00Buy$2.50∞ UpsidePDPInvesco Dorsey Wright Momentum ETF 2.68Moderate Buy$107.72N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOV(COV)N/AN/AN/AN/AN/AN/AHEMHemostemixN/AN/AC$0.01 per share10.77C($0.10) per shareN/AMDNAMedicenna TherapeuticsN/AN/AN/AN/A$0.32 per shareN/APDPInvesco Dorsey Wright Momentum ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOV(COV)N/AN/A0.00N/AN/AN/AN/AN/AN/AHEMHemostemix-C$5.00M-C$0.03N/A∞N/AN/A37.07%-349.24%N/AMDNAMedicenna Therapeutics-$7.60M-$0.09N/AN/AN/AN/A-42.68%-35.17%N/APDPInvesco Dorsey Wright Momentum ETFN/AN/A27.88∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOV(COV)N/AN/AN/AN/AN/AHEMHemostemixN/AN/AN/AN/AN/AMDNAMedicenna TherapeuticsN/AN/AN/AN/AN/APDPInvesco Dorsey Wright Momentum ETF$0.180.17%N/AN/AN/ALatest HEM, COV, MDNA, and PDP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/23/2025PDPInvesco Dorsey Wright Momentum ETFQuarterly$0.04290.16%6/23/20256/23/20256/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOV(COV)N/AN/AN/AHEMHemostemix-55.070.040.48MDNAMedicenna TherapeuticsN/A9.579.57PDPInvesco Dorsey Wright Momentum ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOV(COV)N/AHEMHemostemixN/AMDNAMedicenna Therapeutics12.38%PDPInvesco Dorsey Wright Momentum ETFN/AInsider OwnershipCompanyInsider OwnershipCOV(COV)N/AHEMHemostemix10.43%MDNAMedicenna Therapeutics33.10%PDPInvesco Dorsey Wright Momentum ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOV(COV)N/AN/AN/ANot OptionableHEMHemostemixN/A145.73 millionN/ANot OptionableMDNAMedicenna Therapeutics1669.64 million46.59 millionNot OptionablePDPInvesco Dorsey Wright Momentum ETFN/A11.85 millionN/AOptionableHEM, COV, MDNA, and PDP HeadlinesRecent News About These CompaniesHigh-Beta & Momentum ETFs to Play on Hints of Easing Trade Tensions?April 23, 2025 | zacks.comETFs For The Brave: Are These High-Octane Funds Your Best Bet To Ride An Upward Market Swing?April 15, 2025 | benzinga.comBuy High Beta & High Momentum ETFs for Near-Term GainsApril 10, 2025 | zacks.comBuy High Beta & High Momentum ETFs for Near-Term GainsApril 10, 2025 | zacks.comInvesco Exchange-Traded Fund Trust Invesco Dorsey Wright Momentum ETFMarch 25, 2025 | fxempire.comFPIZ Invesco Dorsey Wright Developed Markets Momentum ETFNovember 22, 2024 | seekingalpha.comPDP, TRGP, WRB, TDG: Large Inflows Detected at ETFOctober 3, 2024 | nasdaq.com(PDP) Investment AnalysisSeptember 17, 2024 | news.stocktradersdaily.comNPDP Invesco Dorsey Wright Momentum ETFAugust 28, 2024 | seekingalpha.comTime for Momentum ETFs?August 20, 2024 | zacks.comMomentum ETFs to Play as Wall Street Rallies?August 16, 2024 | zacks.comInvesco Dorsey Wright Momentum ETF (PDP)November 28, 2023 | finance.yahoo.comInvesco DWA Developed Markets Momentum ETF (PIZ)August 18, 2023 | investing.comInvesco DWA Emerging Markets Momentum ETFJune 30, 2023 | thestreet.comIs Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?February 24, 2023 | msn.comGTO Invesco Actively Managed Exchange-Traded Fund Trust - Invesco Total Return Bond ETFFebruary 23, 2023 | seekingalpha.comInvesco DWA Consumer Cyclicals Momentum ETF (PEZ)December 25, 2022 | finance.yahoo.comPEZ Invesco Exchange-Traded Fund Trust - Invesco DWA Consumer Cyclicals Momentum ETFOctober 11, 2022 | seekingalpha.comInvesco DWA Momentum ETF declares quarterly distribution of $0.0830September 21, 2022 | seekingalpha.comInvesco DWA Momentum ETF declares quarterly distribution of $0.0237June 21, 2022 | seekingalpha.comMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Top-Rated Energy Companies Staging Strong RecoveriesBy Nathan Reiff | June 2, 2025View 3 Top-Rated Energy Companies Staging Strong Recoveries3 Companies to Buy on This Early Cycle RecoveryBy Gabriel Osorio-Mazilli | June 3, 2025View 3 Companies to Buy on This Early Cycle Recovery3 Penny Stocks Analysts Believe Are Headed HigherBy Chris Markoch | June 4, 2025View 3 Penny Stocks Analysts Believe Are Headed HigherNear 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a LookBy Chris Markoch | May 31, 2025View Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a LookThese 3 Dividend Stocks Combine Strong Yields With UpsideBy Chris Markoch | June 20, 2025View These 3 Dividend Stocks Combine Strong Yields With UpsideHEM, COV, MDNA, and PDP Company Descriptions(COV) NYSE:COVCovidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.Hemostemix CVE:HEMC$0.14 +0.01 (+3.85%) As of 06/27/2025 03:51 PM EasternHemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.Medicenna Therapeutics NASDAQ:MDNAMedicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.Invesco Dorsey Wright Momentum ETF NASDAQ:PDP$107.72 +0.62 (+0.58%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$107.73 +0.01 (+0.01%) As of 06/27/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PowerShares DWA Technical Leaders Portfolio (the Fund) is based on the Dorsey Wright Technical Leaders Index (the Index). The Fund seeks investment results that generally correspond to the price and yield of the Index. The Fund will normally invest at least 90% of its total assets in securities that consists of the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index includes approximately 100 the United States-listed companies. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
